{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:03:59Z","timestamp":1789164239785,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["15529"],"award-info":[{"award-number":["15529"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.149644","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:01:40Z","timestamp":1765440100000},"page":"149644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P2","title":["Structural and functional insights into naturally occurring apolipoprotein E variants with protective effects against Alzheimer's disease"],"prefix":"10.1016","volume":"337","author":[{"given":"Daphne","family":"Georgiadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Chroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.149644_bb0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104724","article-title":"APOE in the normal brain","volume":"136","author":"Flowers","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-2275(20)38094-9","article-title":"Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes","volume":"23","author":"Zannis","year":"1982","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer's disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5551\/jat.65393","article-title":"Impact of apolipoprotein E variants: a review of naturally occurring variants and clinical features","volume":"32","author":"Matsunaga","year":"2025","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0040","doi-asserted-by":"crossref","first-page":"50380","DOI":"10.1074\/jbc.M204898200","article-title":"Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease","volume":"277","author":"Morrow","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"Suppl","key":"10.1016\/j.ijbiomac.2025.149644_bb0045","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS","volume":"50","author":"Mahley","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0050","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.1106420108","article-title":"Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions","volume":"108","author":"Chen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0055","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1705080114","article-title":"A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions","volume":"114","author":"Frieden","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0060","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.1617523114","article-title":"Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry","volume":"114","author":"Chetty","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0065","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1126\/science.2063194","article-title":"Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E","volume":"252","author":"Wilson","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215371120","article-title":"Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms","volume":"120","author":"Stuchell-Brereton","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0075","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1021\/acs.jpcb.4c04738","article-title":"Quantitative assessment of conformational heterogeneity in apolipoprotein E4 using hydrogen-deuterium exchange mass spectrometry","volume":"128","author":"Dolai","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169036","article-title":"Investigation of domain interaction in the apolipoprotein E isoforms by HDX-MS","volume":"437","author":"Pal","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0085","doi-asserted-by":"crossref","first-page":"36758","DOI":"10.1074\/jbc.M005565200","article-title":"Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid","volume":"275","author":"Perugini","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1529\/biophysj.104.046813","article-title":"Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution","volume":"88","author":"Chou","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0100","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1074\/jbc.M113.538124","article-title":"Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4","volume":"289","author":"Argyri","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0105","doi-asserted-by":"crossref","first-page":"30654","DOI":"10.1038\/srep30654","article-title":"The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific","volume":"6","author":"Dafnis","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0110","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1194\/jlr.M088732","article-title":"Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy","volume":"59","author":"Katsarou","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0115","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuron.2023.12.018","article-title":"Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteins","volume":"112","author":"Strickland","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1194\/jlr.M600545-JLR200","article-title":"Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution","volume":"48","author":"Peters-Libeu","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0125","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0130","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1056\/NEJMoa2308583","article-title":"APOE3 Christchurch heterozygosity and autosomal dominant Alzheimer\u2019s disease","volume":"390","author":"Quiroz","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41392-024-01775-7","article-title":"Resilience conferred by APOE-R136S: a defense bestowed by nature to combat Alzheimer\u2019s disease","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S1474-4422(25)00116-4","article-title":"Protective genetic variants against Alzheimer\u2019s disease","volume":"24","author":"Marino","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-9-11","article-title":"ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease","volume":"9","author":"Medway","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0150","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","article-title":"Association of rare APOE missense variants V236E and R251G with risk of Alzheimer disease","volume":"79","author":"Le Guen","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9375","article-title":"APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pep.2011.06.011","article-title":"A simple approach for human recombinant apolipoprotein E4 expression and purification","volume":"79","author":"Argyri","year":"2011","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1194\/jlr.M030965","article-title":"Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy","volume":"54","author":"Georgiadou","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/prep.1999.1069","article-title":"Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli","volume":"16","author":"Morrow","year":"1999","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0175","doi-asserted-by":"crossref","first-page":"38570","DOI":"10.1074\/jbc.M111.260422","article-title":"Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization","volume":"286","author":"Mei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0180","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/bi00731a008","article-title":"Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine","volume":"12","author":"Morrisett","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027037","article-title":"Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia","volume":"6","author":"Georgiadou","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140535","article-title":"Apolipoprotein E4 exhibits intermediates with domain interaction","volume":"1868","author":"Dolai","year":"2020","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0195","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1074\/jbc.M205232200","article-title":"The central helices of apoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type apoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo","volume":"278","author":"Chroni","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0200","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00018-020-03583-y","article-title":"Structure-function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk","volume":"78","author":"Gkolfinopoulou","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.freeradbiomed.2021.05.022","article-title":"Mechanistic insight into the capacity of natural polar phenolic compounds to abolish Alzheimer\u2019s disease-associated pathogenic effects of apoE4 forms","volume":"171","author":"Mountaki","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0210","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1021\/bi000099m","article-title":"Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain","volume":"39","author":"Morrow","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0215","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.1021\/bi8015857","article-title":"Biophysical properties of apolipoprotein E4 variants: implications in molecular mechanisms of correction of hypertriglyceridemia","volume":"47","author":"Gorshkova","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0220","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bpc.2005.07.009","article-title":"The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure","volume":"119","author":"Clement-Collin","year":"2006","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0225","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/S0021-9258(18)68778-2","article-title":"Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains","volume":"263","author":"Wetterau","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0230","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1016\/S0021-9258(18)68779-4","article-title":"Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains","volume":"263","author":"Aggerbeck","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0235","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1007\/s12035-023-03529-y","article-title":"Reexamining the causes and effects of cholesterol deposition in the brains of patients with Alzheimer\u2019s disease","volume":"60","author":"Hu","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2014.05.007","article-title":"ATP-binding cassette transporter A1: from metabolism to neurodegeneration","volume":"72 Pt A","author":"Koldamova","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0245","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-2275(20)31622-9","article-title":"Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth","volume":"42","author":"DeMattos","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/089771503321532824","article-title":"Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury","volume":"20","author":"Kay","year":"2003","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2009.12.001","article-title":"Cerebrospinal fluid apolipoprotein E concentration decreases after seizure","volume":"19","author":"Wang","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0260","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.1523\/JNEUROSCI.20-22-08401.2000","article-title":"Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases","volume":"20","author":"Hashimoto","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0265","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.25455","article-title":"Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease","volume":"85","author":"Wadhwani","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0270","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/glia.23974","article-title":"Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation","volume":"69","author":"Lanfranco","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0275","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.stemcr.2019.08.004","article-title":"PSEN1DeltaE9, APPswe, and APOE4 confer disparate phenotypes in human iPSC-derived microglia","volume":"13","author":"Konttinen","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0280","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI96429","article-title":"Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation","volume":"128","author":"Liao","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1388-1981(02)00263-9","article-title":"Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism","volume":"1584","author":"Acharya","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0290","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/cells10030597","article-title":"Apolipoprotein mimetic peptides: potential new therapies for cardiovascular diseases","volume":"10","author":"Wolska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.149644_bb0295","article-title":"Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I","volume":"1865","author":"Gkolfinopoulou","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025102018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025102018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:35:52Z","timestamp":1781512552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025102018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":59,"alternative-id":["S0141813025102018"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149644","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and functional insights into naturally occurring apolipoprotein E variants with protective effects against Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"149644"}}